Toth Financial Advisory Corp acquired a new stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The fund acquired 9,000 shares of the company's stock, valued at approximately $665,000.
A number of other large investors have also bought and sold shares of RYAN. Rakuten Securities Inc. acquired a new stake in shares of Ryan Specialty in the fourth quarter valued at approximately $27,000. Kapitalo Investimentos Ltda acquired a new stake in Ryan Specialty in the 4th quarter valued at $36,000. Principal Securities Inc. lifted its position in Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company's stock worth $43,000 after buying an additional 415 shares in the last quarter. Mizuho Bank Ltd. acquired a new position in shares of Ryan Specialty during the 4th quarter worth about $49,000. Finally, Headlands Technologies LLC boosted its stake in shares of Ryan Specialty by 2,644.8% during the 4th quarter. Headlands Technologies LLC now owns 796 shares of the company's stock worth $51,000 after buying an additional 767 shares during the last quarter. 84.82% of the stock is owned by institutional investors.
Insider Buying and Selling
In other news, Director David P. Bolger sold 5,000 shares of the business's stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total transaction of $354,000.00. Following the sale, the director now directly owns 71,467 shares in the company, valued at approximately $5,059,863.60. The trade was a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the company's stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The disclosure for this sale can be found here. 52.21% of the stock is owned by corporate insiders.
Ryan Specialty Price Performance
Ryan Specialty stock traded down $0.93 during mid-day trading on Tuesday, reaching $65.33. 979,772 shares of the company were exchanged, compared to its average volume of 991,188. The firm has a market cap of $17.15 billion, a PE ratio of 94.69, a PEG ratio of 1.19 and a beta of 0.70. Ryan Specialty Holdings, Inc. has a 12 month low of $52.34 and a 12 month high of $77.16. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company has a fifty day simple moving average of $69.45 and a 200-day simple moving average of $68.64.
Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.39. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The business had revenue of $690.17 million for the quarter, compared to analysts' expectations of $680.80 million. During the same period last year, the firm posted $0.35 earnings per share. The firm's quarterly revenue was up 25.0% compared to the same quarter last year. As a group, equities research analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.
Ryan Specialty Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 0.73%. The ex-dividend date was Tuesday, May 13th. Ryan Specialty's dividend payout ratio (DPR) is presently 141.18%.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on the company. Royal Bank of Canada lowered their target price on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday, February 21st. The Goldman Sachs Group raised Ryan Specialty from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $74.00 to $81.00 in a report on Tuesday, May 13th. Wells Fargo & Company reduced their target price on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. Barclays lowered their price target on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a report on Friday, April 11th. Finally, Keefe, Bruyette & Woods reduced their price objective on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $75.58.
Check Out Our Latest Stock Analysis on Ryan Specialty
Ryan Specialty Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Read More

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.